Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

REVSØRE SMEDIE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.7%   Bankruptcy risk   1.8% 2.2% 2.0% 1.5% 1.8% 1.8% 13.0% 10.5%   Credit score (0-100)   73 68 69 77 70 71 17 23   Credit rating   A BBB A A A A BB BB   Credit limit (kDKK)   1.7 0.2 0.4 12.0 1.5 1.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   969 797 980 992 878 884 0.0 0.0   EBITDA   493 275 466 504 385 394 0.0 0.0   EBIT   319 96.3 259 389 312 360 0.0 0.0   Pre-tax profit (PTP)   319.9 100.3 263.7 382.7 296.5 350.5 0.0 0.0   Net earnings   238.3 63.7 187.9 289.8 233.7 280.0 0.0 0.0   Pre-tax profit without non-rec. items   320 100 264 383 296 351 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   512 672 501 386 368 334 0.0 0.0   Shareholders equity total   2,710 2,774 2,962 1,851 1,785 1,815 1,065 1,065   Interest-bearing liabilities   0.0 0.0 0.0 0.0 242 56.3 0.0 0.0   Balance sheet total (assets)   2,971 2,974 3,220 2,240 2,256 2,227 1,065 1,065   Net Debt   -1,992 -1,875 -2,416 -1,091 -1,466 -1,518 -1,065 -1,065     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   969 797 980 992 878 884 0.0 0.0   Gross profit growth   -7.3% -17.8% 23.0% 1.1% -11.5% 0.7% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,971 2,974 3,220 2,240 2,256 2,227 1,065 1,065   Balance sheet change%   11.1% 0.1% 8.3% -30.4% 0.7% -1.3% -52.2% 0.0%   Added value   319.2 96.3 258.8 389.0 312.4 360.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -342 -18 -379 -230 -91 -68 -334 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   32.9% 12.1% 26.4% 39.2% 35.6% 40.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.3% 3.4% 8.5% 14.4% 13.9% 16.1% 0.0% 0.0%   ROI %   12.3% 3.7% 9.2% 16.4% 16.1% 18.5% 0.0% 0.0%   ROE %   9.2% 2.3% 6.6% 12.0% 12.9% 15.6% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   91.2% 93.3% 92.0% 82.7% 79.1% 81.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -403.9% -682.9% -518.7% -216.7% -380.8% -384.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 13.6% 3.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 13.1% 6.6% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   9.1 11.1 10.2 4.6 3.9 4.4 0.0 0.0   Current Ratio   9.4 11.5 10.5 4.8 4.0 4.6 0.0 0.0   Cash and cash equivalent   1,992.1 1,875.4 2,416.3 1,091.5 1,708.6 1,574.2 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,198.0 2,101.5 2,460.9 1,465.5 1,417.5 1,481.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   319 96 259 389 312 360 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   493 275 466 504 385 394 0 0   EBIT / employee   319 96 259 389 312 360 0 0   Net earnings / employee   238 64 188 290 234 280 0 0